- White House offers $916 billion stimulus proposal
- Pfizer's COVID-19 vaccine gets positive FDA review
- FireEye stock (FEYE.US) fell 9% after cyber attack
US indices launched today’s session mostly higher, after the S&P and the Nasdaq closed at fresh record highs yesterday, as growing confidence that US lawmakers will agree on a coronavirus relief package and further optimistic news regarding Covid-19 vaccine lifted market sentiment. US FDA said Pfizer/BioNTech Covid-19 vaccine “met the prescribed success criteria” clearing it for emergency use approval while the UK rolled out the first doses to the public on Tuesday. Meanwhile, Treasury Secretary Steven Mnuchin presented a $916 billion coronavirus relief proposal via Twitter. The offer includes only $ 40 billion in unemployment benefits, an amount that Democratic leaders found to be far too low. However, the fact that the Trump administration resumed talks for the first time since the elections saw the markets as a sign that a compromise could be reached later this year. On the pandemic front, US reported 209 756 new infections on Tuesday, the third highest on record. Number of hospitalizations reached new record-high of 104,600.
US30 has been trading in an upward trend recently. Currently index is testing resistance at 30265 pts where ATH are located. This level also coincides with an earlier broken upward trendline. However, if sellers will manage to halt declines here, then downward impulse towards 30000 pts level could be launched. Source: xStation5.FireEye (FEYE.US) stock plunged more than 9% in premarket after company announced its systems were breached by hackers in what it said was a highly sophisticated attack by a foreign government. The cybersecurity company confirmed the target of the attack was information about government clients.
FireEye (FEYE.US) stock launched today’s session lower and is trading below major resistance at $14.30 which is additionally strengthened by 50 SMA ( green line). If the current sentiment prevails, the downward move could be extended to the $13.35 handle. Source: xStation5Moderna (MRNA.US) is partnering with Switzerland's Roche (ROG.CH) in connection with its ongoing Covid-19 vaccine trial, incorporating a Roche antibody test in the trial to demonstrate if the vaccine is working.
Campbell Soup (CPB.US) stock rose over 1% in premarket, after company reported quarterly earnings of $1.02 per share, while analysts' expected earnings of $0.91. Revenue also beat market forecasts. The food maker also raised its quarterly dividend by 6% to 37 cents per share.
United Natural Foods (UNFI.US) plunged 13% in premarket after company reported quarterly earnings of 51 cents per share, well below market expectations of the 74 cents a share. Revenue also came in below analysts' expectations. The wholesale grocery distributor reported a slightly higher profit margins, however expenses increased compare to previous year.
Roku (ROKU.US) – Citi lifted its price target on the company's stock to a Street-high $375 per share from $220 and maintained its “buy” rating. Citi is raising its estimate of expected value per active account and sees an increase in several factors, including new distribution deals.
